Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sigmoid Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Fractures, Bone 1Emergence Delirium 1Colonic Neoplasms 1

Interventions

pembrolizumab 35Nivolumab 14Docetaxel 11atezolizumab 10Paclitaxel 9Carboplatin 7Gemcitabine 6Cisplatin 6Trastuzumab 5Magnetic Resonance Spectroscopy 5Ipilimumab 5Fluorodeoxyglucose F18 5Cyclophosphamide 5Bevacizumab 5fludarabine 4avelumab 4Specimen Handling 4Psychiatric Rehabilitation 4Oxaliplatin 4Leucovorin 4Fluorouracil 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4cemiplimab 3Taxes 3Polymerase Chain Reaction 3Pemetrexed 3Irinotecan 3Gene Expression Profiling 3Early Intervention, Educational 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Neuroleptanalgesia × Genitourinary × Clear all
NCT05068180 2021-10-06

Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients

RenJi Hospital

Phase 4 Unknown
200 enrolled
GastrointestinalGenitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Liver Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sigmoid Neoplasms, Stomach Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡